Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study

Yun Yong Seo, Yong Kyun Cho, Ji-Cheol Bae, Mi Hae Seo, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee

Endocrinol Metab. 2013;28(1):41-45. Published online March 25, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.1.41

Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study

Yun Yong Seo, Yong Kyun Cho, Ji-Cheol Bae, Mi Hae Seo, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee

Endocrinology and Metabolism. 2013;28(1):41

Link1 Link2 Link3

Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease

Anna Mae Diehl

Clinics in Liver Disease. 2004;8(3):619-638

Link1 Link2

Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression

Walid E. Zahran, Kholoud A. Salah El-Dien, Philip G. Kamel, Ahmed Shawky El-Sawaby

Indian Journal of Clinical Biochemistry. 2012;28(2):141-146

Link1

Link2 Link3

Nonalcoholic fatty liver disease in children: A follow-up study for up to 16 years

Ariel E. Feldstein, Mounif El-Youssef, Deborah K. Freese, Keith D. Lindor, Paul Angulo

Gastroenterology. 2003;124(4):A701

Link1 Link2

PP4 LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR-α FACTOR (LITAF) AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

A. Alisi, N. Panera, A. Masotti, L. Da Sacco, M. Pezzullo, R. De Vito, S. Petrini, M. Manco, V. Nobili

Digestive and Liver Disease. 2010;42:S331

Link1 Link2

Body fat changes and activity of tumor necrosis factor α system—a 5-year follow-up study

Magdalena Olszanecka-Glinianowicz, Jerzy Chudek, Piotr Kocełak, Adam Szromek, Barbara Zahorska-Markiewicz

Metabolism. 2011;60(4):531-536

Link1 Link2

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study

Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Ulf Hammar, Per Stål, Rolf Hultcrantz, Stergios Kechagias

Hepatology Communications. 2017;2(1):48-57

Link1 Link2 Link3 Link4

Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers

Mazen Noureddin, Rohit Loomba

Clinical Liver Disease. 2012;1(4):104-107

Link1 Link2

Introductory Chapter: Nonalcoholic Fatty Liver Disease - What Should We Know?

Emad Hamdy Gad, Yasmin Kamel

Nonalcoholic Fatty Liver Disease - An Update. 2019;

Link1

GI Epidemiology: nonalcoholic fatty liver disease

P. ANGULO

Alimentary Pharmacology & Therapeutics. 2007;25(8):883-889

Link1 Link2